Treace Medical Concepts, Inc. (TMCI)

Treace Medical Concepts Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	12.61	10.71	11.35	12.98	19.47	105.83
Short-Term Investments	33.01	37.66	64.33	110.22	61.78	-
Cash & Short-Term Investments	45.62	48.37	75.68	123.2	81.25	105.83
Cash Growth	-34.16%	-36.09%	-38.57%	51.63%	-23.23%	485.39%
Accounts Receivable	28.73	42.16	40.8	38.06	29.2	18.57
Other Receivables	0.3	0.3	0.6	1.1	0.4	-
Receivables	29.03	42.46	41.4	39.16	29.6	18.57
Inventory	39.54	36.03	39.26	29.25	19.33	10.56
Prepaid Expenses	6.26	5.2	5.07	6.75	3.22	3.01
Total Current Assets	120.45	132.05	161.4	198.36	133.4	137.97
Property, Plant & Equipment	39.64	37.37	34.4	31.56	25.48	2.85
Goodwill	12.82	12.82	12.82	12.82	-	-
Other Intangible Assets	6.65	7.13	8.08	9.03	-	-
Other Long-Term Assets	1.5	1.22	0.41	0.15	0.15	-
Total Assets	181.06	190.58	217.09	251.91	159.02	140.82

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	16.06	6.73	10.52	11.84	8.67	4.06
Accrued Expenses	21.11	21.48	21.77	25.43	21.24	14.15
Short-Term Debt	3.53	1.75	-	-	-	-
Current Portion of Leases	0.39	0.55	0.41	1.4	0.34	-
Other Current Liabilities	0.41	0.13	2.22	6.37	-	-
Total Current Liabilities	41.5	30.64	34.93	45.03	30.25	18.21
Long-Term Debt	56.04	55.58	53.31	53.01	52.71	29.54
Long-Term Leases	13.09	13.98	15.93	15.89	15.54	-
Other Long-Term Liabilities	2.69	3.05	0.04	0.04	-	-
Total Liabilities	113.32	103.25	104.2	113.97	98.5	47.75

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.07	0.06	0.06	0.06	0.06	0.05
Additional Paid-In Capital	351.97	337.37	303	271.97	145.22	134.93
Retained Earnings	-282.83	-248.99	-189.99	-134.25	-84.72	-41.91
Treasury Stock	-1.42	-1.18	-0.28	-0.01	-	-
Comprehensive Income & Other	-0.05	0.07	0.1	0.16	-0.03	-
Total Common Equity	67.74	87.33	112.89	137.94	60.53	93.07
Shareholders' Equity	67.74	87.33	112.89	137.94	60.53	93.07
Total Liabilities & Equity	181.06	190.58	217.09	251.91	159.02	140.82

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	73.05	71.86	69.65	70.3	68.59	29.54
Net Cash (Debt)	-27.43	-23.5	6.02	52.9	12.66	76.3
Net Cash Growth	-	-	-88.61%	317.71%	-83.40%	-
Net Cash Per Share	-0.43	-0.37	0.10	0.87	0.23	1.58
Filing Date Shares Outstanding	65.03	63.86	62.36	61.75	61.16	54.75
Total Common Shares Outstanding	64.98	63.86	62.36	61.75	55.63	54.18
Working Capital	78.96	101.42	126.48	153.33	103.16	119.76
Book Value Per Share	1.04	1.37	1.81	2.23	1.09	1.72
Tangible Book Value	48.27	67.39	92	116.1	60.53	93.07
Tangible Book Value Per Share	0.74	1.06	1.48	1.88	1.09	1.72
Machinery	44.55	40.6	29.48	20.19	12.32	5.06
Construction In Progress	0.2	1.07	0.61	1.12	0.71	0.13
Leasehold Improvements	10.72	10.59	10.24	9.43	6.43	0.27

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Aug 7, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 29, 2026

Data Sources Report a data error